Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-α, IL-1β and IL-10 by human leucocytes

Immunology

Volumn 91, Issue 2, 1997, Pages 193-196

  Van Furth, A M ^a,b   Verhard Seijmonsbergen, E M ^a   Van Furth, R ^a,c   Langermans, J A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; LISOFYLLINE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0030975513     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00252.x     Document Type: Article

References (25)

1. VAN FURTH A.M., SEIJMONSBERGEN E.M., LANGERMANS J.A.M., VAN DER MEIDE P.M.P. & VAN FURTH R. (1995) Effect of Xanthine-derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin 1β (IL-1β) and IL-10 by human leukocytes. Clin Diagn Lab Immunol 2, 689-692.
2. VAN FURTH A.M., STEENWIJK T.M., LANGERMANS J.A. & VAN FURTH R. (1994) In vitro effect of dexamethasone, pentoxifylline, and anti-endotoxin monoclonal antibody on the release of proinflammatory mediators by human leukocytes stimulated with Haemophilus influenzae type B. Pediatr Res 35, 725-728.
3. STRIETER R.M., REMICK D.G., WARD P.A. et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155, 1230-1235.
4. NEUNER P., KLOSNER G., SCHAUER E. et al. (1994) Pentoxifylline in vivo down-regulates the release of IL-1β, IL-6, IL-8 and tumour necrosis factor-α by human peripheral blood mononuclear cells. Immunology 83, 262-267.
5. RICE G.C., BROWN P.A., NELSON R.J., BIANCO J.A., SINGER J.W. & BURTSEN S. (1994) Protection from endotoxic shock in mice by pharmacologic inihibition of phosphatidic acid. Proc Natl Acad Sci USA 91, 3857-3861.
6. SINGER J.W., BURSTEN S.L., RICE G.C., GORDON W.P. & BIANCO J.A. (1994) Inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications. Exp Opin Invest Drugs 3(6), 631-643.
7. EISEMAN E., FINNEY R., CAI F. et al. (1995) Lisofylline inhibits the induction of stress activated protein kinase (SAPK) and proinflammatory cytokines by taxol. Blood 86: S 692a.
8. BURSTEN S., WEEKS R., WEST J. et al. (1994) Potential role for phosphatidic acid in mediating the inflammatory responses to TNF-α and IL-1β. Circ Shock 44, 14-29.
9. ENDRES S. (1993) Messengers and mediators: interactions among lipids, eicosanoids, and cytokines. Am J Clin Nutr 57, 798S-800S.
10. HAN J., THOMPSON P. & BEUTLER B. (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172, 391-394.
11. SAEZ-LLORENS X., RAMILO O., MUSTAFA M.M. et al. (1990) Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrob Agents Chemother 34, 837-843.
12. SCHANDENE L., VANDENBUSSCHE P., CRUSIAUX A. et al. (1992) Differential effects of pentoxifylline on the production of tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells. Immunology 76, 30-34.
13. SEMMLER J., GEBERT U., EISENHUT T. et al. (1993) Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 78, 520-525.
14. HASKILL S. JOHNSON C., EIERMAN D., BECKER S. & WARREN K. (1988) Adherence induces selective mRNA expression of monocyte mediatorsand protooncogenes. J Immunol 140, 1690-1694.
15. KUHNS D.B., ALVORD W.G. & GALLIN J.L. (1995) Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans J Infect Dis 171: 145-152.
16. VON DER MÖHLEN M.A.M., KIMMINGS A.N., WEDEL N.I. et al. (1995) Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability - increasing protein J Infect Dis 172, 144-151.
17. VAN DEVENTER S.J.H., BÜLLER H.R., TEN CATE J.W. et al. (1990) Experimental Endotoxemia in humans: Analysis of cytokine release and coagulation, fybrinolytic and complement pathways Blood 76, 2520-2526.
18. DERKX B.H.F., BRUIN K.F., JONGENEEL V. et al. (1995) Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro: relationship to HLA-haplotype and TNF gene polymorphism J Endotox Res 2, 19-25.
19. DUBRAVEC D.B., SPRIGGS D.R., MANNICK J.A. & RODRICK M.L. (1990) Circulating human periphral blood granulocytes synthesize and secrete tumor necrosis factor a Proc Natl Acad Sci USA 87, 6758-6761.
20. CASSALATA M.A. (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16, 21-26.
21. HOWARD M. & O'GARRA A. (1992) Biological properties of IL-10. Immunol Today 13, 198-200.
22. VAN DER POLL T., JANSEN J., LEVY M., TEN CATE J.W. & VAN DEVENTER S.J.H. (1994) Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 180: 1985-1988.
23. PLATZER C., MEISEL CH, VOGT K., PLATZER M. & VOLK H.-D (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs Int Immunol 7, 517-523.
24. MEISEL CH, VOGT K., PLATZER C., RANDOW F., LIEBENTHAL CH. & VOLK H.-D (1996) Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression. Eur J Immunol 26, 1580-1586.
25. WESTENDORP R.G.J., LANGERMANS J.A.M., HUIZINGA T.W.J. et al. (1997) Genetic influence on cytokine production and fatal meningococcal disease Lancet 349, 170-173.